A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...
Two sisters have issued a warning after losing both of their healthy parents to a 'silent killer' form of cancer ...
Researchers from NTU Hospital and Academia Sinica have developed PanMETAI, a breakthrough AI metabolomics platform for early ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...
Jean Trebek, Lisa Swayze, Joan Vassos, Stephen Nichols, Jeff Mauro, Jonathan Frakes, Kitty Swink, Rosa Blasi and Many More Raise [...] READ MORE ...
Piedmont Oncology announced a significant philanthropic gift to support its Early Detection Pancreatic Cancer Clinic (EDC) and to establish an endowed medical director position for the clinic. This ...
Huge improvements in prevention, diagnosis and treatment have driven the fall, Cancer Research UK says ...
MELBOURNE, Australia, March 12, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company focused on developing novel treatments for chronic ...
Cancer death rates in the UK have hit a record low, but the picture is more complicated than the headline figure suggests.
The two blockbusters have made a big difference in bladder cancer survival, but will their chemistry hold up when tested in other types?
Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results